Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Oscar Health's change in receivables for the quarter that ended in Jun. 2026 was MXN26,492 Mil. It means Oscar Health's Accounts Receivable
declined by MXN26,492 Mil
from Mar. 2026 to Jun. 2026 .
Oscar Health's change in receivables for the fiscal year that ended in Dec. 2025 was MXN1,775 Mil. It means Oscar Health's Accounts Receivable
declined by MXN1,775 Mil
from Dec. 2024 to Dec. 2025 .
Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Oscar Health's Days Sales Outstanding for the
three
months ended in Jun. 2026 was 14.16.
In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Oscar Health's liquidation value for the
three
months ended in Jun. 2026 was MXN-839 Mil.
Oscar Health (MEX:OSCR) Change In Receivables Explanation
1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
Oscar Health's Days Sales Outstanding for the quarter that ended in Jun. 2026 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Oscar Health Change In Receivables Related Terms
Oscar Health Change In Receivables Historical Data
* Premium members only.
The historical data trend for Oscar Health's Change In Receivables can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.
Change In Receivables for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN38,053 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Change In Receivables of MXN38,053 Mil mean?
Oscar Health (MEX:OSCR) has a Change In Receivables of MXN38,053 Mil as of Jun. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Oscar Health and its competitors.
Is Oscar Health's Change In Receivables too high?
Oscar Health's current Change In Receivables is MXN38,053 Mil. Overall, Oscar Health has a GF Score™ of 49/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Oscar Health's Change In Receivables compare to MOH and ALHC?
Oscar Health's Change In Receivables of MXN38,053 Mil can be compared against companies in the Healthcare Plans industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Plans company?
A good Change In Receivables depends on the Healthcare Plans industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Oscar Health and its competitors. Oscar Health's current Change In Receivables is MXN38,053 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oscar Health stock overvalued right now?
Based on GuruFocus' analysis, Oscar Health (MEX:OSCR) is currently considered Modestly Overvalued. The stock's GF Value™ is MXN408.83, compared to a current price of MXN494.01 — trading 20.8% above its estimated fair value. The current Change In Receivables is MXN38,053 Mil. Oscar Health's overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Oscar Health (MEX:OSCR), the current Change In Receivables is MXN38,053 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Oscar Health (MEX:OSCR) Overvalued in 2026?
Based on GuruFocus' analysis, Oscar Health stock appears to be overvalued.
The current stock price of MXN494.01 is trading 20.8% above its estimated GF Value™ of MXN408.83.
GuruFocus considers Oscar Health to be Modestly Overvalued.
Key valuation signals for MEX:OSCR:
Change In Receivables: MXN38,053 Mil
GF Value™: MXN408.83 vs. price of MXN494.01 (20.8% above fair value)
No single metric tells the full story. See the MEX:OSCR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Oscar Health Inc is a healthcare technology company built around a full stack technology platform and a relentless focus on serving its members. It offers Individual & Family plans and health technology solutions that power the healthcare industry. Oscar operates as one segment to sell insurance to individuals, families and employees through the federal and state-run healthcare exchanges formed in conjunction with the Patient Protection and Affordable Care Act (ACA) and leverages its technology platform to provide services via its Oscar offering.
49GF Score
Get the complete analysis for MEX:OSCR
Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:OSCR has been successfully added to your 
